Biotech strategy and nanomedicine: the pharmaphorum podcast

from pharmaphorum Podcast · host pharmaphorum

For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.

Episode metadata supplied by the publisher feed · Published Dec 21, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Biotech strategy and nanomedicine: the pharmaphorum podcast

0:00 20:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 20 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on December 21, 2018.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!